By Sabela Ojea
Acelyrin said that Chief Financial Officer Gil Labrucherie has resigned and will be leave on Jan. 2 to pursue another opportunity.
The late-stage clinical biopharmaceutical company on Tuesday said that Labrucherie will provide consulting services to the through March 31 at an hourly rate of $500.
The company didn't detail plans on the search for a successor.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
December 10, 2024 17:33 ET (22:33 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments